🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xingui Liu

ORCID: 0000-0003-2659-8007
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity”.

Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity

Nature Communications(2020)10.1038/s41467-020-15838-0
N/A
0.838DataRank · unranked
266 citations

Xuan Zhang, Jianhui Chang, Ha‐Neui Kim, Peiyi Zhang, Yingying Wang +17 more

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies

Journal of Hematology & Oncology(2020)10.1186/s13045-020-00924-z
N/A
0DataRank · unranked
123 citations

Sajid Khan, Zhiguang Huo, Dongwen Lv, Xuan Zhang, Xingui Liu +6 more

Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity

European Journal of Medicinal Chemistry(2020)10.1016/j.ejmech.2020.112186
N/A
0DataRank · unranked
115 citations

Dinesh Thummuri, Xingui Liu, Wanyi Hu, Peiyi Zhang, Sajid Khan +4 more

A Facile Semisynthesis and Evaluation of Garcinoic Acid and Its Analogs for the Inhibition of Human DNA Polymerase β

Molecules(2020)10.3390/molecules25245847
N/A
0DataRank · unranked
5 citations

Maroof K. Zafar, Xingui Liu, Robert L. Eoff, Guangrong Zheng, G. Satheesh

Deuteration of the farnesyl terminal methyl groups of δ-tocotrienol and its effects on the metabolic stability and ability of inducing G-CSF production

Bioorganic & Medicinal Chemistry(2020)10.1016/j.bmc.2020.115498
N/A
0DataRank · unranked
8 citations

Zhengya Gao, Qiang Fu, Lin Song, Peiyi Zhang, Xuan Zhang +5 more

PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

Exploration of Targeted Anti-tumor Therapy(2020)10.37349/etat.2020.00017
N/A
0DataRank · unranked
23 citations

Xuan Zhang, Xingui Liu, Sajid Khan, Daohong Zhou, Guangrong Zheng +1 more

Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,

Nature Communications(2021)10.1038/s41467-021-27210-x
N/A
0DataRank · unranked
149 citations

Pratik Pal, Xingui Liu, Yannan Jia, Dinesh Thummuri, Peiyi Zhang +19 more

Piperlongumine (PL) conjugates induce targeted protein degradation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.21.474712
N/A
0DataRank · unranked
6 citations

Yufeng Xiao, Xingui Liu, Wanyi Hu, Amin Sobh, Yaxia Yuan +12 more

Piperlongumine conjugates induce targeted protein degradation

Cell chemical biology(2023)10.1016/j.chembiol.2023.01.004
N/A
0DataRank · unranked
71 citations

Yufeng Xiao, Xingui Liu, Wanyi Hu, Amin Sobh, Yaxia Yuan +12 more

Design and optimization of piperlongumine analogs as potent senolytics

Bioorganic & Medicinal Chemistry Letters(2023)10.1016/j.bmcl.2023.129593
N/A
0DataRank · unranked
4 citations

Yonghan He, Xingui Liu, Xin Zhang, Peizhong Shi, Yingying Wang +3 more

Discovery of XZ338, a highly potent BCL-XL degrader

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.117624
N/A
0DataRank · unranked
5 citations

Dinesh Thummuri, Wanyi Hu, Xingui Liu, Peiyi Zhang, Shuo Zhou +3 more